Skip to main content
. 2021 Mar 16;73(4):1275–1289. doi: 10.1002/hep.31462

Fig. 2.

Fig. 2

Kapla‐Meier analyses of hepatic decompensation in the derivation cohort. A, All patients, as well as the subgroups of patients with cACLD (i.e., first hepatic decompensation) (B) and dACLD (i.e., further hepatic decompensation) (C), stratified according to their risk of posttreatment clinically significant portal hypertension (CSPH, HVPG ≥ 10 mm Hg).